Geographic · Property, plant and equipment, net

United States — Property, plant and equipment, net

Moderna United States — Property, plant and equipment, net decreased by 4.2% to $1.47B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.2%, from $1.53B to $1.47B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2021
Last reportedQ4 2025Feb 20, 2026
Rolls up toPP&E (Net)

How to read this metric

An increase typically signals significant capital expenditure for facility expansion or manufacturing capacity, while a decrease may reflect asset depreciation, divestitures, or a shift toward outsourced production models.

Detailed definition

This metric represents the net book value of tangible long-term assets located within the United States, including manuf...

Peer comparison

Biotech firms with internal manufacturing capabilities show higher levels of these assets compared to 'asset-light' companies that rely primarily on contract manufacturing organizations.

Metric ID: mrna_segment_united_states_property_plant_and_equipment_net

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$1.05B$1.27B$1.56B$1.53B$1.47B
QoQ Change+20.7%+23.1%-1.8%-4.2%
YoY Change+20.7%+23.1%-1.8%-4.2%
Range$1.05B$1.56B
CAGR+39.8%
Avg YoY Growth+9.5%
Median YoY Growth+9.4%
Current Streak2 quarters decline

Frequently Asked Questions

What is Moderna's united states — property, plant and equipment, net?
Moderna (MRNA) reported united states — property, plant and equipment, net of $1.47B in Q4 2025.
How has Moderna's united states — property, plant and equipment, net changed year-over-year?
Moderna's united states — property, plant and equipment, net decreased by 4.2% year-over-year, from $1.53B to $1.47B.
What does united states — property, plant and equipment, net mean?
The total value of the company's physical assets and facilities located in the United States, minus accumulated depreciation.